Europe Amniotic Membrane Market Forecast 2022-2030
KEY FINDINGS
The Europe amniotic membrane market is projected to register a CAGR of 6.92% during the forecast period, 2022-2030. The rising applications in oral surgery and ophthalmology and the growing geriatric population are the key drivers of market growth.
MARKET INSIGHTS
Italy, Russia, Belgium, Poland, Germany, France, the United Kingdom, and Rest of Europe are analyzed for the Europe amniotic membrane market growth assessment. Germany has a large number of healthcare facilities and hospitals that facilitate AM (amniotic membrane) treatment. Also, tissue donation is encouraged in the country. For instance, the Germany Society for Tissue Transplantation organizes nationwide tissue donation and offers bone grafts, blood vessels, heart valves, amniotic tissue, and corneal transplants.
Further, AM tissue transplants are part of the standard medical care in Germany. In addition, German doctors have transplanted hundreds of bone preparations and cardiovascular tissues and almost 60,000 corneas. In Italy, AM tissue donations increased between 2013 and 2020. As a result, it is an emerging market for AM use. Additionally, AM use is on the rise in wound care, ophthalmology, and dermatology, alongside various institutes conducting research on the same for the last 12 years.
Further, in Russia, the market growth is driven by the growing number of surgeries, the rising disease awareness, and the increasing R&D investments in stem cell and regenerative medicine fields. At the same time, the lack of stringent regulations and awareness are expected to affect the market growth.
COMPETITIVE INSIGHTS
Some of the prominent market players are Labtician Ophthalmics Inc, Integra LifeSciences Corp, Stryker Corporation, Amniox Medical Inc, Celularity Inc, etc.
Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Incidents Of Burn Injuries And Traumatic Wounds
- 3.1.2. Increasing Research On Stem Cell Biology And Regenerative Medicine
- 3.1.3. Awareness Programs For Wound Care Treatment
- 3.2. Key Restraints
- 3.2.1. Limitations Associated With Use Of Amniotic Membrane
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Amniotic Membrane Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 5. Market By Product
- 5.1. Cryopreserved Amniotic Membrane
- 5.2. Lyophilization Amniotic Membrane
- 6. Market By Application
- 6.1. Surgical Wounds
- 6.2. Ophthalmology
- 6.3. Other Applications
- 7. Market By End-users
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centers
- 7.3. Specialized Clinics
- 7.4. Research Centers & Laboratories
- 8. Geographical Analysis
- 8.1. Europe
- 8.1.1. Market Size & Estimates
- 8.1.2. Key Growth Enablers
- 8.1.3. Key Challenges
- 8.1.4. Key Players
- 8.1.5. Country Analysis
- 8.1.5.1. United Kingdom
- 8.1.5.2. Germany
- 8.1.5.3. France
- 8.1.5.4. Italy
- 8.1.5.5. Russia
- 8.1.5.6. Belgium
- 8.1.5.7. Poland
- 8.1.5.8. Rest Of Europe
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.2. Company Profiles
- 9.2.1. Amino Technology Llc
- 9.2.2. Amino X Medical Inc
- 9.2.3. Bio-tissue Inc
- 9.2.4. Celularity Inc
- 9.2.5. Human Regenerative Technologies
- 9.2.6. Integra Lifesciences Corp
- 9.2.7. Katena Products Inc
- 9.2.8. Labtician Ophthalmics Inc
- 9.2.9. Mimedx
- 9.2.10. Organogenesis Inc
- 9.2.11. Skye Biologics Llc
- 9.2.12. Smith & Nephew Plc
- 9.2.13. Stryker Corporation
- 9.2.14. Surgenex Llc
- 9.2.15. Surgilogix Llc
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook